News

Seres Therapeutics Set to Release Q3 Financial Results Soon

Seres Therapeutics Set to Release Q3 Financial Results Soon

Seres Therapeutics Announces Upcoming Conference Call

CAMBRIDGE, Mass. — Seres Therapeutics, Inc. (NASDAQ: MCRB), a prominent player in the live biotherapeutics sector, is gearing up to share its third quarter 2024 financial results. Scheduled for November 13, 2024, at 8:30 a.m. ET, the live audio webcast and conference call will allow stakeholders to gain insight into the company’s financial performance and strategic updates.

How to Access the Event

Interested parties can participate in the conference call by calling 800-715-9871 for domestic inquiries or 646-307-1963 for international connections, using conference ID number 5051385. For a more visual engagement, attendees can join the live webcast by heading over to the “Investors and News” section of the official Seres Therapeutics website.

Replay Availability

A recording of the webcast will be accessible on the Seres Therapeutics website, typically available about two hours post-event and will remain archived for roughly 21 days, offering investors and interested individuals a chance to catch up on the latest updates they may have missed.

Understanding Seres Therapeutics

Seres Therapeutics, Inc. (NASDAQ: MCRB) stands at the forefront of innovation in the biotherapeutics landscape. The company is dedicated to enhancing patient outcomes, particularly for those in medically vulnerable populations, through its pioneering work with live biotherapeutics. An exciting achievement has been the successful development of VOWST™, marking it as the first FDA-approved orally administered microbiome therapeutic, now in the hands of Nestlé Health Science following its acquisition in September 2024.

Current Pipeline Developments

Moreover, the company is progressing with SER-155, which has shown promising results in a clinical trial involving allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) patients. This treatment has significantly reduced bloodstream infections and related complications compared to traditional placebo treatments. The innovative approach that Seres combines with its other developmental programs aims to tackle various disease-relevant pathways and utilizes standard clonal cell banks through single-strain cultivation techniques instead of relying on the donor-sourced production process previously used for VOWST.

Future Product Goals

Seres Therapeutics is committed to furthering its mission by advancing additional cultivated oral live biotherapeutics targeted at medically vulnerable segments, including patients suffering from chronic liver disease, those undergoing cancer treatments that cause neutropenia, and individuals needing solid organ transplants. The company's exploration and dedication to novel treatments promise to push the boundaries in therapeutic care for these vulnerable populations.

Investor Relations Contact

For inquiries regarding investments and media relations, interested parties can reach out via email at IR@serestherapeutics.com. Carlo Tanzi, Ph.D., from Kendall Investor Relations, is ready to assist with any related inquiries. You can also contact him directly at ctanzi@kendallir.com.

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The conference call aims to discuss Seres Therapeutics' third quarter 2024 financial results and share notable business updates.

When will the conference call take place?

The call is scheduled for November 13, 2024, at 8:30 a.m. ET.

How can I access the live audio webcast?

Participants can join the live webcast by visiting the “Investors and News” section of the Seres Therapeutics website.

What recent achievement has Seres Therapeutics noted?

Seres succeeded in developing VOWST™, the first FDA-approved orally administered microbiome therapeutic, now sold to Nestlé Health Science.

What is SER-155 and its significance?

SER-155 is being developed to address complications in patients undergoing allogeneic Hematopoietic Stem Cell Transplantation, showing a significant reduction in bloodstream infections.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 4

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kelly Advances Pediatrics with Children's Therapy Center Buyout

Updated Category News Views 324

Kelly Expands Pediatric Therapy Reach Through Strategic Acquisition Kelly has recently made a significant move in the therapeutic services sector by acquiring the Children's Therapy Center (CTC). This strategic acquisition marks an essential growth opportunity for Kelly, especially as it pertains to pediatric therapy services. With increasing demands for specialized...

Continue Reading
Insights into Rathbones Group's Recent Stake in Warehouse REIT

Updated Category News Views 154

Key Information on Rathbones Group Plc's Investment In a recent public disclosure, Rathbones Group Plc revealed their significant interests in Warehouse REIT Plc, a company known for its strategic holdings in the warehouse sector. This disclosure is crucial for investors keen on understanding market movements and the implications of major shareholdings. Who is Rathbones...

Continue Reading
Exploring the Surge of Pharmaceutical Contract Sales Market

Updated Category News Views 191

Pharmaceutical Contract Sales Organization Market Overview The pharmaceutical contract sales organization market is set to grow from US$ 8.21 billion in 2022 to US$ 15.82 billion by 2030, boasting a compound annual growth rate (CAGR) of 8.6%. This growth stems from a notable increase in pharmaceutical companies globally seeking specialized sales support and innovative...

Continue Reading
Generational Group Facilitates Clareblend, Inc. Sale Success

Updated Category News Views 74

Generational Group Facilitates Clareblend, Inc. Sale Success Generational Group, a prominent mergers and acquisitions advisory firm dedicated to privately held businesses, proudly announces a significant achievement in the sale of its client, Clareblend, Inc., to the esteemed Silhouet-Tone. This successful acquisition marks a vital step for Clareblend in its journey...

Continue Reading
Dietary Guidelines Highlight Eggs as Nutrient-Dense Superfood

Updated Category News Views 203

Emphasizing the Importance of Protein in Diets The new dietary guidelines stress the necessity of incorporating protein in meals across all age groups, especially emphasizing the nutritional benefits of eggs. As adults and children alike pursue healthier eating habits, eggs have emerged as a paramount source of high-quality protein, offering essential nutrients necessary...

Continue Reading